Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glucreta M 5/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Dapagliflozin (5mg) + Metformin (500mg)

Overview Glucreta M 5/500 Tablet ER

Metformin/glimepiride extended-release tablets (5mg/500mg) are a dual-action medication for managing type 2 diabetes. They work to regulate elevated blood glucose, lessening the likelihood of severe diabetic complications and contributing to heart health protection. This medication can be taken with meals, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation, as abrupt cessation may elevate blood sugar, increasing risks like kidney impairment and vision loss. This medication forms one element of a comprehensive diabetes plan incorporating a balanced diet, physical activity, and weight management as directed by your doctor. Common side effects can include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital yeast infections are a potential side effect; diligent hygiene is recommended for prevention. Prior to starting this treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before commencing therapy. Limit alcohol consumption during treatment as it may exacerbate side effects. Regular blood glucose monitoring is essential during therapy.

Uses of Glucreta M 5/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Glucreta M 5/500 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glucreta M 5/500 Tablet ER with a meal.

Common Side effects of Glucreta M 5/500 Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Glucreta M 5/500 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glucreta M 5/500 Extended-Release Tablets should be administered with a meal.

How Glucreta M 5/500 Tablet ER works:

Dapagliflozin and Metformin, combined as Glucreta M 5/500 Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates glucose excretion via the kidneys, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glucreta M 5/500 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glucreta M 5/500 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glucreta M 5/500 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glucreta M 5/500 Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glucreta M 5/500 Extended-Release tablets. Dosage modifications for Glucreta M 5/500 Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Glucreta M 5/500 Tablet ER :

Should you forget a Glucreta M 5/500 Tablet ER dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glucreta M 5/500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Glucreta M 5/500 Tablet E...
81
MRP 94
13% off